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PP-103 Horizontal transmission of hepatitis B (HB)
among non-immune paediatric patients at the
National Cancer Institute of Sri Lanka (NCISL)
C.G.U.A. Patabendige1 *, A. Pinnaduwa1, C. Hallala1.
1National Cancer Institute of Sri Lanka, Sri Lanka
Objectives:
• To determine seroconversion rate of immuno-
compromised children following HB vaccination.
• To determine seroconversion rate of mothers/guardians
following vaccination.
• To determine percentage of non-immune children
developing HB when on close contact.
Methods: A prospective descriptive study was carried out
for two years from January 2007. Blood collected from
all new children (113 in 2007 and 208 in 2008) and
guardians (109 in 2007 and 279 in 2008) on admission
were tested for HBsAg. HBs Negative candidates were given
full course of vaccination. HBs antibodies were checked
06 weeks after the last dose. Positive candidates are
immune and if negative HB vaccination was repeated. If
HBs antibodies are still negative, they are non-responders.
If one develops clinical evidence of HB infection while
undergoing vaccination, they were checked for HBsAg to
detect infection.
Results: Rate of seroconversion in children after ﬁrst course
of vaccination in 2007 is 64.60% while that for 2008 is
87.01%. Following two courses of vaccination in children
seroconversion rates are higher which are 92.92% and
94.23% respectively. In guardians, after the ﬁrst course,
seroconversion rates are 76.14% and 85.66% respectively.
Following the two courses, the rates of seroconversion
of guardians are very high with 97.24% and 98.20% for
2007 and 2008 respectively. There are 20 non-responders
among children and 08 among guardians. Percentage of
children who are non-responders developing disease is
higher compared to the percentage of children developing
HB while on vaccination. None of the children who became
immune following HB vaccination developed hepatitis B
infection.
Conclusion: Contact isolation of hepatitis B infected
children is essential to prevent horizontal transmission
through close contact to immuno-compromised children who
are non responders and also to children during vaccination.
Continuation of existing policy for HB vaccination is
needed.
PP-104 An evaluation on quality of life in patients with
liver cirrhosis after S-adenosylmethionine
(SAM-e) therapy
J. Liu1 *, L. Peng1. 1The Third Afﬁliated Hospital of Sun
Yat-sen University, China
Background: To explore the quality of life (QOL) for HBV-
related liver cirrhosis (LC) patients. And the effect of SAM-e
therapy on QOL in patients with LC was evaluated.
Methods: A study based on 60 patients with LC (group A,
before SAM-e therapy, T0) and 60 healthy persons (group B)
was carried out using SF-36 questionnaire, and QOL were
compared between these two groups. After being given
SAM-e injection (1.0/d) therapy of two weeks (T1), group A
were given SAM-e tablets (1.0/d) therapy of two weeks (T2),
subsequently. At the same time 60 patients with LC without
SAM-e therapy (group C) were investigated. QOL were
compared using SF-36 questionnaire on T0, T1 and T2.
Results: Compared with group B, group A had lower QOL on
all scales and total scores (P < 0.05) of the SF-36 except for
PF and MH. On T1/T2 group B had higher QOL on GH, RP,
RE, VT, MH and total scores than before (P < 0.05). On T2
group B had higher QOL on GH, RP, RE and total scores than
that on T1 (P < 0.05).
Conclusion: QOL of patients with LC is more impaired than
healthy persons. SAM-e therapy will improve the QOL, and
the improvement will be strengthened with SAM-e tablets
therapy after the injection therapy.
PP-105 Screening of the target genes transactivated by
PS1TP2 protein with suppression subtractive
hybridization technique
J.-L. Chen1 *, J. Guo1, J. Cheng1. 1Beijing Ditan Hospital,
Capital Medical University, Beijing 100015, China
Background: PS1TP2 is one of genes transactivated by
pre-S1. Its function is unknown. To get insight into the
transactivation mechanism of PS1TP2 protein, the SSH was
used for identiﬁcation of transactivating relative target
genes of PS1TP2 protein.
Methods Suppression subtractive hybridization technique
and bioinformatics technique were used, the mRNA from
HepG2 cells transfected with pcDNA3.1( )-PS1TP2 and
pcDNA3.1( ) empty vector was isolated, respectively; cDNA
was synthesized. After digestion with restriction enzyme
RsaI, cDNA fragments were obtained. Tester cDNA was
then divided into two groups and ligated to the speciﬁc
adaptor 1 and adaptor 2, respectively. After tester cDNAwas
hybridized with driver cDNA twice and underwent two times
of nested PCR, ampliﬁed cDNA fragments were subcloned
into pGEM-Teasy vectors to set up the subtractive library.
Ampliﬁcation of the library was carried out with E. coli strain
DH5a. The cDNA was sequenced and analyzed in GenBank
with Blast search after PCR.
Results: The subtractive library of genes transactivated by
PS1TP2 was constructed successfully (Table 1).
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Conclusion: The obtained sequences may be target genes
transactivated by PS1TP2 protein among which some
genes coding proteins involved in cell cycle regulation,
metabolism, immunity and cell apoptosis. This ﬁnding
brought some clues for studying the biological functions
of PS1TP2.
PP-106 Study of the association of hepatitis B
surface antigen and HLA with hepatocellular
carcinoma
S. Zaki1 *, A. Abd El Moety2, M. Mehasseb3. 1Microbiology,
Faculty of Medicine, Alexandria University, 2Internal
Medicine, Faculty of Medicine, Alexandria University,
3Physiology, Medical Research Institute Alexandria
University, Egypt
Introduction: Primary liver cancer accounts for only
1 2% of malignant tumors found at autopsy in western
countries. However, in some parts of Africa and Asia it
may account for up to 20 30% of all types of malignancy.
The high frequency of HBsAg positivity in individuals with
Hepatocellular Carcinoma (HCC) strongly suggests that
chronic HBV infection may contribute in some way towards
the development of 1ry liver cell carcinoma. Although HCC is
probably caused by one or more environmental carcinogens,
a hereditary predisposition to the tumor has not been
excluded.
Aim: Determine the incidence of HBsAg carriers patients
suffering from primary HCC and detect the association
between primary HCC and HLA.
Subjects and Methods: The material consisted of twenty
patients diagnosed as HCC based on Ultrasonographic ex-
amination and by Histopathology. Laboratory investigations;
liver biopsy, HBsAg, Anti-HBcAg (IgM) and HLA typing using
lymphocyte microcytotoxicity technique.
Results: The 20 studied cases were negative for HBcAb IgM
and 10 patients were positive for HBsAg. HLA typing revealed
signiﬁcant rise of HLA-A9, HLA-B5 among HCC patients. HLA-
A9 was signiﬁcantly increased in HBsAg positive and negative
cases. HLA-B5 was signiﬁcantly increased in HBsAg positive
cases only while HLA-B8 was signiﬁcantly increased in HBsAg
negative cases only.
In cases with mixed hepatic cirrhosis and Schistosomal
hepatic ﬁbrosis which were negative for HBsAg showed
signiﬁcant increase in HLA-A9.
Conclusions:
1. Signiﬁcant association of HBsAg positivity in patients
with HCC.
2. Signiﬁcant association of HLA-A9 and HLA-B5 with HCC.
3. HLA-A9 in patients mixed cirrhosis and Schistosomal
hepatic ﬁbrosis may be predisposing to HCC.
PP-107 Lentivirus mediated shRNA interference
targeting DR1 and CP region of HBV genome
stably inhibits viral replication in vitro
W.W. Wang1 *, K.K. Hu1. 1Wuhan Institute of Virology, CAS,
China
RNAi is a potential tool for antiviral therapy. However,
plasmid-based shRNA and chemically synthetic siRNA are
ineffective in treating viral infection due to limited
transfection efﬁciency and short half-life. Thus, non-
replicating recombinant viral vectors, in particular lentiviral
DNA which can integrate into host genome, may represent
effective means in antiviral treatment. In order to study
the kinetics of gene silencing, it is desirable to suppress
genes in a regulated fashion. Such regulated RNAi system
can provide a way to express shRNA only when needed or
only in certain cells. Traditional anti-HBV drugs, such as
nucleoside analogues and interferon-a, are only partially
effective in reducing viral loads.
Here we applied the regulated lentiviral delivery system
to investigate the suppressive effect of siRNA on HBV.
We compared two expression systems, a DNA-based vector
(pSuper) under H1 promoter and the lentiviral vector, to
deliver siRNA targeting the direct repeat 1 (DR1) region,
the core promoter (CP) region or the reverse transcriptase
(RT) of HBV genome. First, we designed and constructed
shRNA into the pSuper vector and assessed the effect on
HBV replication in HepG2.2.15 cells. We found that the
shRNA targeting DR1 region (1826nt-1845nt) or the CP region
(1775nt-1795nt) signiﬁcantly suppressed HBV replication,
while shRNA targeting RT only had moderate effect. We
subsequently cloned shRNA cassettes targeting DR1 region
and CP region into the lentiviral vector, respectively.
Recombinant lentiviruses were transduced into HepG2.2.15
cells with 95% efﬁcacy as evidenced by ﬂuorescence
microscopy, resulting in great reduction at both mRNA
and protein levels which were maintained to 96h post-
transduction.
We are currently constructing the tetracycline operator
system into the lentiviral vector to generate a tetracycline
based-regulated RNAi system. This conditional RNAi system
will provide a promising tool to analyze siRNA-mediated
anti-HBV therapy.
PP-108 Prevalence of transfusion-transmitted virus in
patients with viral liver disease
L. Zhuang1 *, J. You2, L. Kong1, H. Lei1, H.-Y. Chen2,
Q.-Q. Wang2. 1Department of Hepatology, Third Municipal
People’s Hospital of Kunming, China, 2Department of
Infectious Diseases, The First Afﬁliated Hospital of
Kunming Medical University, China
Aim: To explore the prevalence of transfusion transmitted
virus (TTV) infection in patients with viral liver diseases.
Methods: TTV DNA in serum from all enrolled patients with
viral liver disease (VLD) was detected with PCR method.
Anti-HAV, HBV-marker, anti-HCV, anti-HDV and anti-HEV
markers were also tested by ELISA. HBVDNA, HCVRNA and
HGV RNA were detected by PCR and RT-PCR method.
Results: The prevalence rate of TTV infection in VLD
patients was 14.7% (43/292). Of all the patients,
the percentage of TTV infection was 5.0% (2/40),
15.9% (29/182), 31.6% (6/19) and 11.8% (6/51), respectively
in patients with acute hepatitis (AH), chronic hepatitis (CH),
severe hepatitis (SH) and liver cirrhosis (LC); in which the
rate of TTV infection with SH predominated (p < 0.001).
Of all the 43 patients with positive TTV in serum,
5 (11.6%) cases were infected with TTV alone, 38 (88.4%)
patients were super-infected with more than one hepatitis
virus (HV). The double infection rate was signiﬁcantly higher
than the single infection rate (p < 0.01). In the group
infected with TTV, there were 2 AH cases (4.7%), 29 CH
cases (67.4%), 6 SH cases (14.0%) and 6 LC cases (14.0%), and
in which CH predominated (p < 0.01). In AH group, 2 cases
infected with TTV, 1 with TTV only, another one was super-
infected with other HV. In CH group (29), 3 with TTV single
infection, 26 with TTV super-infection. In SH group, 1 was
with TTV single infection, 5 with TTV super-infected. In
LC group, all patients were TTV super-infected. In the group
infected with TTV only, most patients had the symptoms of
CH (60%). In the group super-infected with HV, most patients
were super-infected with HBV (89.5%, 34/38). The super-
infection group was composed of AH, CH, SH and LC (2.6%,
68.4%, 13.2%, and 15.8% respectively).
Conclusions: TTV infection is common in patients with viral
liver disease. TTV is frequently super-infected with other
